Glycosidases in cancer and invasion.

PubWeight™: 1.00‹?› | Rank: Top 15%

🔗 View Article (PMID 3888385)

Published in Cancer Metastasis Rev on January 01, 1985

Authors

R J Bernacki, M J Niedbala, W Korytnyk

Articles by these authors

Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis. Arthritis Rheum (1996) 1.60

Syntheses and structure-activity relationships of the second-generation antitumor taxoids: exceptional activity against drug-resistant cancer cells. J Med Chem (1996) 1.52

Interactions of human ovarian tumor cells with human mesothelial cells grown on extracellular matrix. An in vitro model system for studying tumor cell adhesion and invasion. Exp Cell Res (1985) 1.32

Synthesis and structure-activity relationships of new second-generation taxoids. Bioorg Med Chem Lett (1999) 1.20

Concomitant elevations in serum sialytransferase activity and sialic acid content in rats with metastasizing mammary tumors. Science (1977) 1.10

Syntheses and structure-activity relationships of taxoids derived from 14 beta-hydroxy-10-deacetylbaccatin III. J Med Chem (1997) 1.09

Activity of paclitaxel liposome formulations against human ovarian tumor xenografts. Int J Cancer (1997) 1.04

Syntheses and biological activity of C-3'-difluoromethyl-taxoids. Bioorg Med Chem (2000) 1.00

Ultrastructural evidence for ectoglycosyltransferase systems. Nature (1975) 1.00

Antitumor activity of N1,N11-bis(ethyl)norspermine against human melanoma xenografts and possible biochemical correlates of drug action. Cancer Res (1993) 0.99

Anti-angiogenic activity of selected receptor tyrosine kinase inhibitors, PD166285 and PD173074: implications for combination treatment with photodynamic therapy. Invest New Drugs (1999) 0.98

Fluorinated carbohydrates as potential plasma membrane modifiers. Synthesis of 4- and 6-fluoro derivatives of 2-acetamido-2-deoxy-D-hexopyranoses. Carbohydr Res (1990) 0.96

Cytotoxicity, cellular accumulation and DNA binding of oxaliplatin isomers. Cancer Lett (1995) 0.96

New taxanes as highly efficient reversal agents for multidrug resistance in cancer cells. Bioorg Med Chem Lett (1998) 0.96

Biochemical characteristics, metabolism, and antitumor activity of several acetylated hexosamines. J Supramol Struct (1977) 0.95

Effects of novel spermine analogues on cell cycle progression and apoptosis in MALME-3M human melanoma cells. Cancer Res (1997) 0.94

Effects of orally active taxanes on P-glycoprotein modulation and colon and breast carcinoma drug resistance. J Natl Cancer Inst (2001) 0.94

Glycosidase activity. Glycosidase acitivity in L5178Y mouse leukemic cells and the activity of acid phosphatase, beta-galactosidase and beta-N-acetylgalactosaminidase and beta-N-acetylglucosaminidase in a synchronous L5178Y cell population. Exp Cell Res (1970) 0.92

Role of galaptin in ovarian carcinoma adhesion to extracellular matrix in vitro. J Cell Biochem (1990) 0.92

Inhibition of lectin-mediated ovarian tumor cell adhesion by sugar analogs. J Biol Chem (1994) 0.92

Synthesis and structure-activity relationships of nonaromatic taxoids: effects of alkyl and alkenyl ester groups on cytotoxicity. J Med Chem (1997) 0.91

Targeting 5'-deoxy-5'-(methylthio)adenosine phosphorylase by 5'-haloalkyl analogues of 5'-deoxy-5'-(methylthio)adenosine. J Med Chem (1991) 0.90

Activated gelatinase-B (MMP-9) and urokinase-type plasminogen activator in synovial fluids of patients with arthritis. Correlation with clinical and experimental variables of inflammation. J Rheumatol (1995) 0.90

In vitro degradation of extracellular matrix by human ovarian carcinoma cells. Clin Exp Metastasis (1987) 0.89

Isolation, cultivation, and partial characterization of microvascular endothelium derived from human lung. Am J Respir Cell Mol Biol (1992) 0.89

Synthesis and biological activity of some 1-N-substituted 2-acetamido-2-deoxy-beta-D-glycopyranosylamine derivatives and related analogs. Carbohydr Res (1980) 0.89

Cytokine activation of human macro- and microvessel-derived endothelial cells. Blood Cells (1993) 0.89

Biochemical effects and therapeutic potential of tunicamycin in murine L1210 leukemia. Cancer Res (1983) 0.88

Localization and activation of type IV collagenase/gelatinase at endothelial focal contacts. Am J Physiol (1997) 0.88

Cell surface n-acetylneuraminic acid alpha2,3-galactoside-dependent intercellular adhesion of human colon cancer cells. Biochem Biophys Res Commun (1999) 0.88

Inhibition of human HT-29 colon carcinoma cell adhesion by a 4-fluoro-glucosamine analogue. Glycoconj J (1996) 0.87

Fluorinated carbohydrates as potential plasma membrane modifiers and inhibitors. Synthesis of 2-acetamido-2,6-dideoxy-6-fluoro-D-galactose. Carbohydr Res (1987) 0.87

Galaptin-mediated adhesion of human ovarian carcinoma A121 cells and detection of cellular galaptin-binding glycoproteins. Cancer Res (1993) 0.87

A correlation between cell surface sialyltransferase, sialic acid, and glycosidase activities and the implantability of B16 murine melanoma. Cancer Res (1981) 0.87

Cancer metastasis: a search for therapeutic inhibition. Cancer Invest (1998) 0.83

The biochemical and ultrastructural effects of tunicamycin and D-glucosamine in L1210 leukemic cells. J Cell Physiol (1983) 0.83

Synthesis of certain nucleoside methylenediphosphonate sugars as potential inhibitors of glycosyltransferases. J Med Chem (1987) 0.83

Plasma membrane ectoglycosyltransferase activity of L1210 murine leukemic cells. J Cell Physiol (1974) 0.82

Adhesion, growth and morphology of human mesothelial cells on extracellular matrix. J Cell Sci (1986) 0.81

Synthesis and physicochemical and biological properties of 6-halogen-substituted vitamin B 6 analogs. J Med Chem (1973) 0.81

Antitumor efficacy of taxane liposomes on a human ovarian tumor xenograft in nude athymic mice. J Pharm Sci (1995) 0.81

Characterization of human ovarian and endometrial carcinoma cell lines established on extracellular matrix. Gynecol Oncol (1989) 0.81

Plasma membrane as a site for chemotherapeutic intervention. Adv Enzyme Regul (1978) 0.80

Effects of nucleotides and nucleotide:analogs on human serum sialyltransferase. Cancer Res (1979) 0.80

Inhibition of human ovarian carcinoma cell- and hexosaminidase- mediated degradation of extracellular matrix by sugar analogs. Anticancer Res (1992) 0.80

Analogs of cell surface carbohydrates. Synthesis of D-galactose derivatives having an ethynyl, vinyl or epoxy residue at C-5. Carbohydr Res (1988) 0.80

Growth of human urological tumors on extracellular matrix as a model for the in vitro cultivation of primary human tumor explants. Cancer Res (1986) 0.80

Role of glycosidases in human ovarian carcinoma cell mediated degradation of subendothelial extracellular matrix. Cancer Res (1987) 0.80

Synthesis of analogs of N-acetylneuraminic acid and their effect on CMP-sialate synthase. Carbohydr Res (1989) 0.79

Fluorinated carbohydrates as potential plasma membrane modifiers. Synthesis of 3-deoxy-3-fluoro derivatives of 2-acetamido-2-deoxy-D-hexopyranoses. Carbohydr Res (1993) 0.79

ROSFIT: an enzyme kinetics nonlinear regression curve fitting package for a microcomputer. Comput Biomed Res (1982) 0.79

Modifications at C-3 and C-4 of 2-amino-2-deoxy-D-glucose. Carbohydr Res (1980) 0.79

Guanylhydrazones with potential antileukemic activity. 2. Synthesis and structure-activity relationships of analogues of 4,4'-diacetyl-N,N'-diphenylurea bis(guanylhydrazone). J Med Chem (1978) 0.79

Antitumor efficacy of N1,N11-diethylnorspermine on a human bladder tumor xenograft in nude athymic mice. Clin Cancer Res (1997) 0.79

Halogenated L-fucose and D-galactose analogues: synthesis and metabolic effects. J Med Chem (1980) 0.79

Ovarian cancer patients with high CA-125 but no symptoms--should antiangiogenic treatments be considered? Oncol Res (1997) 0.78

Pepstatins: aspartic proteinase inhibitors having potential therapeutic applications. Med Res Rev (1993) 0.78

Modulation of human mammary cell sensitivity to paclitaxel by new quinoline sulfonamides. Bioorg Med Chem Lett (2001) 0.78

Activity of a rat-liver glycoprotein: sialyltransferase utilizing desialyzed prothrombin as an acceptor in normal and hypothrombinemic animals. Eur J Biochem (1973) 0.78

Antimetastatic activity of adriamycin in combinations with proteinase inhibitors in mice. Anticancer Res (1990) 0.78

Synthesis of glycopyranosylphosphonate analogues of certain natural nucleoside diphosphate sugars as potential inhibitors of glycosyltransferases. J Med Chem (1987) 0.78

Properties of 4-ethenyl and 4-ethynyl analogs of pyridoxal phosphate and their reactions with the apo form of asparatate aminotransferase. J Biol Chem (1975) 0.78

Rat-liver-sialidase activity utilizing a tritium-labeled sialic-acid derivative of glycoprotein substrates. Activity in normal and hypothrombinemic rats. Eur J Biochem (1973) 0.78

A high-performance liquid chromatography method for the assay of cytidine monophosphate-sialic acid synthetase. Anal Biochem (1983) 0.77

General methods for modification of sialic acid at C-9. Synthesis of N-acetyl-9-deoxy-9-fluoroneuraminic acid. Carbohydr Res (1988) 0.77

Some short-chain N6-substituted adenosine analogues with antitumor properties. J Med Chem (1980) 0.77

1-beta-D-arabinofuranosylcytosine conjugates of ether and thioether phospholipids. A new class of ara-C prodrug with improved antitumor activity. Lipids (1991) 0.77

The effects of sucrose and various salts on the growth and lysosomal enzyme activity of L5178Y cells. J Cell Sci (1971) 0.77

Human ovarian carcinoma beta-N-acetylglucosaminidase isoenzymes and their role in extracellular matrix degradation. Cancer Res (1989) 0.77

Elevation of lysosomal enzymes in primary Lewis lung tumor correlated with the initiation of metastasis. Cancer Res (1980) 0.77

Phosphorylated analogs of vitamin B 6 modified in the 5' position and on the phosphate group: synthesis and interaction with pyridoxine phosphate oxidase and certain apoenzymes. Biochemistry (1972) 0.77

Regulation of rat-liver glycoprotein: N-acetylneuraminic acid transferase activity by pyrimidine nucleotides. Eur J Biochem (1975) 0.77

On the inhibitory activity of 4-vinyl analogues of pyridoxal: enzyme and cell culture studies. Biochemistry (1976) 0.76

Combinations of mesna with cyclophosphamide or adriamycin in the treatment of mice with tumors. Cancer Res (1987) 0.76

Evaluation of antitumor and antimetastatic activity of pepstatin A in some experimental tumor models. J Chemother (1989) 0.76

Galactosyltransferase activity and cell growth: uridine diphosphate (UDP)galactose inhibition of murine leukemic L1210 cells. J Cell Physiol (1984) 0.76

The use of a novel taxane-based P-glycoprotein inhibitor to identify mutations that alter the interaction of the protein with paclitaxel. Mol Pharmacol (2001) 0.76

Vitamin B6 antagonists obtained by replacing or modifying the 2-methyl group. J Med Chem (1977) 0.76

Activity of tunicamycin against Trypanosoma brucei in vitro and in vivo. Antimicrob Agents Chemother (1982) 0.75

Editorial review of Dr. Darryl Rideout's article entitled "Self-assembling drugs: A new approach to biochemical modulation in cancer chemotherapy. Cancer Invest (1994) 0.75

2'-Fluorinated isonucleosides. 1. Synthesis and biological activity of some methyl 2'-deoxy-2'-fluoro-2'-pyrimidinyl-D-arabinopyranosides. J Med Chem (1989) 0.75

Effects of a membrane sugar analogue, 6-deoxy-6-fluoro-D-galactose, on the L1210 leukemic cell ectosialyltransferase system. Biochem Pharmacol (1983) 0.75

An evaluation of the effects of combination chemotherapy in vitro using DNA-reactive agents. Cancer Drug Deliv (1985) 0.75

Insulin-modulated interleukin-2 production by murine splenocytes and a T-cell hybridoma. J Endocrinol (1987) 0.75

Therapeutic and diabetogenic potential of two newly synthesized nitrosoureido sugars. Cancer Res (1985) 0.75

Synergistic interactions of ethidium bromide and bleomycin on cellular DNA and growth inhibition. Biochem Biophys Res Commun (1984) 0.75

Antitumor properties of tetrahydrobenz[a]anthraquinone derivatives. J Med Chem (1990) 0.75

2'-fluorinated pyrimidine isonucleosides. Novel nucleoside analogs demonstrate therapeutic activity in mice with tumors. Nucleic Acids Symp Ser (1987) 0.75